DT402

· Definium Therapeutics US, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DT402, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2A Trial of DT402 for Autism Spectrum Disorder [Phase 2]